Naidoo Alicia, Kajee Afsana, Mvelase Nomonde R, Swe-Han Khine Swe
Department of Medical Microbiology, RK Khan Laboratory, National Health Laboratory Service, Durban, South Africa.
Department of Medical Microbiology, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Afr J Lab Med. 2023 Mar 3;12(1):1920. doi: 10.4102/ajlm.v12i1.1920. eCollection 2023.
Urinary tract infections are common bacterial infections affecting millions worldwide. Although treatment options for urinary tract infections are well established, with ciprofloxacin long considered one of the antibiotics of choice, increasing antibiotic resistance may delay the initiation of appropriate therapy. While this increase in antimicrobial resistance has been demonstrated in multiple studies around the world, there is a dearth of information from developing countries.
This study aimed to describe the antimicrobial susceptibility patterns of commonly isolated bacterial uropathogens in a South African hospital.
Antimicrobial susceptibility data of isolates obtained from urine specimens at the RK Khan Hospital, a regional hospital in KwaZulu-Natal, South Africa, between January 2018 and December 2020 were retrieved from the hospital's laboratory information system and analysed to determine the differences in resistance rates between the most frequently isolated bacterial uropathogens.
Of the 3048 bacterial urinary pathogens isolated between 2018 and 2020, (1603; 53%) was the most common, followed by spp. (437; 14%). Both and spp. showed high rates of resistance to amoxicillin/clavulanic acid (29.8% and 42.3%) and ciprofloxacin (37.7% and 30.4%). Nitrofurantoin resistance was low among (6.2%) but high among spp. (61.3%).
and spp. in this study were highly resistant to amoxicillin/clavulanic acid and ciprofloxacin, two of the frequently prescribed oral treatment options.
This study highlights the importance of regular local antimicrobial resistance surveillance to inform appropriate empiric therapy.
尿路感染是常见的细菌感染,全球数以百万计的人受其影响。尽管尿路感染的治疗方案已很成熟,环丙沙星长期以来一直被视为首选抗生素之一,但抗生素耐药性的增加可能会延迟适当治疗的开始。虽然全球多项研究已证实抗菌药物耐药性有所增加,但发展中国家的相关信息却很匮乏。
本研究旨在描述南非一家医院中常见的尿路致病菌的抗菌药敏模式。
从南非夸祖鲁 - 纳塔尔省一家地区医院RK汗医院2018年1月至2020年12月期间尿液标本中分离出的菌株的抗菌药敏数据,从医院的实验室信息系统中检索并进行分析,以确定最常分离出的尿路致病菌之间的耐药率差异。
在2018年至2020年分离出的3048株细菌性尿路致病菌中,大肠埃希菌(1603株;53%)最为常见,其次是肺炎克雷伯菌属(437株;14%)。大肠埃希菌和肺炎克雷伯菌属对阿莫西林/克拉维酸(分别为29.8%和42.3%)和环丙沙星(分别为37.7%和30.4%)均表现出较高的耐药率。呋喃妥因在大肠埃希菌中的耐药率较低(6.2%),但在肺炎克雷伯菌属中较高(61.3%)。
本研究中的大肠埃希菌和肺炎克雷伯菌属对阿莫西林/克拉维酸和环丙沙星这两种常用的口服治疗药物具有高度耐药性。
本研究强调了定期进行当地抗菌药物耐药性监测以指导适当经验性治疗的重要性。